Tag: Oncology

Aster DM Healthcare partners AP’s Narayanadri Hospital to expand India presence

businessnewstoday- October 5, 2022

Aster DM Healthcare has partnered with Andhra Pradesh’s Narayanadri Hospital to expand its hospital operations management services in India. The partnership is part of the ... Read More

Aura Biosciences begins dosing in belzupacap sarotalocan phase 1 trial in NMIBC

businessnewstoday- October 2, 2022

Aura Biosciences said that it has dosed the first patient in a phase 1 clinical trial of its first virus-like drug conjugate (VDC) — belzupacap ... Read More

Ayala Pharmaceuticals AL102 gets FDA fast track status in desmoid tumors

businessnewstoday- September 29, 2022

Ayala Pharmaceuticals has been granted fast track designation for its oral gamma-secretase inhibitor AL102 by the US Food and Drug Administration (FDA) for the treatment ... Read More

Marker Therapeutics gets FDA approval for MT-601 IND in r/r NHL

- August 7, 2022

Marker Therapeutics said that the US Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for MT-601 for the treatment of ... Read More

AstraZeneca, Daiichi Sankyo get Enhertu FDA approval for HER2-low metastatic breast cancer

- August 7, 2022

Enhertu FDA approval : AstraZeneca and Daiichi Sankyo have secured approval for Enhertu (trastuzumab deruxtecan) from the US Food and Drug Administration for the treatment ... Read More

Innovent Biologics, Sanofi to expedite development of cancer drugs in China

- August 6, 2022

Chinese biopharma company Innovent Biologics and French pharma giant Sanofi have entered into a partnership that aims to bring innovative drugs to patients in China ... Read More

BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC

- August 6, 2022

BriaCell Therapeutics has signed an exclusive licensing deal with the University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a ... Read More

HUTCHMED begins HMPL-A83 phase 1 trial in advanced malignant neoplasms

- July 18, 2022

HUTCHMED (China) has launched a phase 1 clinical trial of its oncology drug candidate HMPL-A83 in China in patients having advanced malignant neoplasms. HMPL-A83 is ... Read More

Lantern Pharma gets FDA nod for Harmonic phase 2 clinical trial of LP-300

- July 17, 2022

Lantern Pharma said that the US Food and Drug Administration (FDA) has authorized it to move ahead with its Harmonic phase 2 clinical trial of ... Read More

Prescient Therapeutics gets FDA orphan drug status for PTX-100 in PTCL

- July 15, 2022

Prescient Therapeutics has secured the orphan drug designation for its PTX-100 compound from the US Food and Drug Administration (FDA) for the treatment of peripheral ... Read More